BIOMAT Database Logo BIOMAT Database Logo

[N,N-dimethyltryptamine and bufotenin in the urine of patients with chronic and acute schizophrenic psychoses]. 1970

H Rosengarten, and A Szemis, and A Piotrowski, and K Romaszewska, and H Matsumoto, and K Stencka, and A Jus

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D006213 Hallucinogens Drugs capable of inducing illusions, hallucinations, delusions, paranoid ideations, and other alterations of mood and thinking. Despite the name, the feature that distinguishes these agents from other classes of drugs is their capacity to induce states of altered perception, thought, and feeling that are not experienced otherwise. Hallucinogen,Hallucinogenic Agent,Hallucinogenic Drug,Hallucinogenic Substance,Psychedelic,Psychedelic Agent,Psychedelic Agents,Psychotomimetic Agent,Psychotomimetic Agents,Hallucinogenic Agents,Hallucinogenic Drugs,Hallucinogenic Substances,Psychedelics,Agent, Hallucinogenic,Agent, Psychedelic,Agent, Psychotomimetic,Agents, Hallucinogenic,Agents, Psychedelic,Agents, Psychotomimetic,Drug, Hallucinogenic,Drugs, Hallucinogenic,Substance, Hallucinogenic,Substances, Hallucinogenic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000208 Acute Disease Disease having a short and relatively severe course. Acute Diseases,Disease, Acute,Diseases, Acute
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012559 Schizophrenia A severe emotional disorder of psychotic depth characteristically marked by a retreat from reality with delusion formation, HALLUCINATIONS, emotional disharmony, and regressive behavior. Dementia Praecox,Schizophrenic Disorders,Disorder, Schizophrenic,Disorders, Schizophrenic,Schizophrenias,Schizophrenic Disorder
D014363 Tryptamines Decarboxylated monoamine derivatives of TRYPTOPHAN. Indolylethylamines,Triptan,Triptans

Related Publications

H Rosengarten, and A Szemis, and A Piotrowski, and K Romaszewska, and H Matsumoto, and K Stencka, and A Jus
Occurrence of bufotenin (5-hydroxy-N,N-dimethyltryptamine) in urine of schizophrenic patients.
August 1967, Life sciences,
H Rosengarten, and A Szemis, and A Piotrowski, and K Romaszewska, and H Matsumoto, and K Stencka, and A Jus
Gas chromatographic-mass spectrometric identification of urinary bufotenin and dimethyltryptamine in drug-free chronic schizophrenic patients.
June 1974, Biological psychiatry,
H Rosengarten, and A Szemis, and A Piotrowski, and K Romaszewska, and H Matsumoto, and K Stencka, and A Jus
Identification of N,N-dimethyltryptamine, 5-methoxy-N,N-dimethyltryptamine and bufotenin by cellulose TLC.
November 1973, Journal of chromatography,
H Rosengarten, and A Szemis, and A Piotrowski, and K Romaszewska, and H Matsumoto, and K Stencka, and A Jus
The determination of bufotenin in urine of schizophrenic patients and normal controls.
June 1972, Journal of psychiatric research,
H Rosengarten, and A Szemis, and A Piotrowski, and K Romaszewska, and H Matsumoto, and K Stencka, and A Jus
Occurrence of bufotenin in the urine of schizophrenic patients and normal persons.
November 1968, Nature,
H Rosengarten, and A Szemis, and A Piotrowski, and K Romaszewska, and H Matsumoto, and K Stencka, and A Jus
[Study on the presence of bufotenin in the urine of schizophrenic patients].
January 1967, Revista de la sanidad militar argentina,
H Rosengarten, and A Szemis, and A Piotrowski, and K Romaszewska, and H Matsumoto, and K Stencka, and A Jus
[Urinary excretion of bufotenin, N,N-dimethyltryptamine and 3,4-dimethoxyphenylethylamine and the clinical picture of mental disorders].
January 1978, Psychiatria polska,
H Rosengarten, and A Szemis, and A Piotrowski, and K Romaszewska, and H Matsumoto, and K Stencka, and A Jus
[Elimination of N,N-dimethyltryptamine by urine].
September 1993, Acta psiquiatrica y psicologica de America latina,
H Rosengarten, and A Szemis, and A Piotrowski, and K Romaszewska, and H Matsumoto, and K Stencka, and A Jus
Acute schizophrenic psychoses.
January 1948, Ser (revista medico-social),
H Rosengarten, and A Szemis, and A Piotrowski, and K Romaszewska, and H Matsumoto, and K Stencka, and A Jus
A sensitive method for the detection of n,n-dimethylserotonin (bufotenin) in urine; failure to demonstrate its presence in the urine of schizophrenic and normal subjects.
October 1965, Journal of psychiatric research,
Copied contents to your clipboard!